Neema Ngugi: Understanding the D-Dimer Test – A Key Tool in Detecting Blood Clots
Neema Ngugi, Nephrology Nurse Nephrology at The Nairobi South Hospital, shared a post on LinkedIn:
“Understanding the D-Dimer Test: A Key Tool in Detecting Blood Clots
The D-Dimer test plays a crucial role in clinical decision-making, especially when evaluating patients for suspected thrombotic events.
It measures fibrin degradation products – essentially fragments produced when a blood clot dissolves in the body.
Why is it done?
Primarily, the D-Dimer test is used to rule out serious clotting conditions such as:
- Deep Vein Thrombosis (DVT)
- Pulmonary Embolism (PE)
- Disseminated Intravascular Coagulation (DIC)
- Stroke or Myocardial Infarction
How to interpret results?
- Normal D-Dimer – Clotting is unlikely
- Elevated D-Dimer – Not diagnostic, but signals the need for further investigation (e.g., imaging studies)
Important to remember:
An elevated D-Dimer is not specific.
Levels can also rise in conditions such as:
- Infection
- Pregnancy
- Recent surgery
- Liver disease
- Cancer
Clinical takeaway:
The D-Dimer test is most powerful when used appropriately – especially in low to moderate-risk patients – to safely exclude life-threatening clotting conditions and avoid unnecessary imaging.
As healthcare professionals, understanding when and how to use this test ensures accurate diagnosis, timely intervention, and improved patient outcomes.”
Stay updated on all scientific advances with Hemostasis Today.
-
Jun 24, 2026, 13:37Heba Youssef: Heparin-Induced Thrombocytopenia – The Prothrombotic Emergency You Cannot Miss
-
Jun 24, 2026, 13:32Jecko Thachil: Understanding the Clinical Spectrum of Vitamin B12
-
Jun 24, 2026, 13:32Namrata Singh: Beyond Low Platelets – Understanding What Triggers ITP
-
Jun 24, 2026, 09:29Advancing Women’s Health Through Collaboration with Jean Hailes for Women’s Health – Stroke Foundation
-
Jun 24, 2026, 09:18The Lasting Immunological Footprint of VITT – JTH
-
Jun 24, 2026, 09:09Umberto Pensato: Dedicated Funding Pathways for Stroke Research in Italy
-
Jun 24, 2026, 09:00Danny Gaskin: BBTS 2026 and the Evolving Role of Transfusion in Maternity Care
-
Jun 24, 2026, 07:46Wolfgang Miesbach: WFH’s First AAV Gene Therapy Chapter Marks a New Era in Hemophilia Care
-
Jun 24, 2026, 06:42Deepthi Krishna: World Blood Donor Day 2026 Celebrations at Rela Hospital